[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2019 Europe Drugs of Abuse Testing Market: Country Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Spain, UK

September 2015 | 300 pages | ID: 21BE551A3D5EN
Venture Planning Group

US$ 5,200.00 US$ 6,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Complete report $6,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500. This new 300-page report from VPGMarketResearch provides a comprehensive analysis of the European drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene. During the next five years, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. 2015-2019 Europe Drugs of Abuse Testing Market” is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; and provides test volume and sales forecasts, by market segment and individual assay. Contains 300 pages and 48 tables
INTRODUCTION

EXECUTIVE SUMMARY

RATIONALE FOR TESTING DECENTRALIZATION
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
1. AIDS
2. Adenovirus
3. Campylobacter
4. Candida
5. Chlamydia
6. Clostridium Difficile
7. Cytomegalovirus
8. Enteroviruses
9. Epstein-Barr Virus
10. Gonorrhea
11. Helicobacter Pylori
12. Hepatitis
  a. Hepatitis A
  b. Hepatitis B
  c. Hepatitis C
  d. Hepatitis D
13. Herpes Simplex Virus
14. Human Herpes Virus-6 (HHV-6)
15. Influenza Viruses
16. Legionella
17. Lyme Disease
18. Measles (Rubeola)
19. Meningitis
20. Mononucleosis
21. Mumps
22. Mycoplasma
23. Papillomaviruses
24. Pneumonia
25. Respiratory Syncytial Virus (RSV)
26. Rheumatoid Arthritis
27. Rotavirus (Reovirus)
28. Rubella (German Measles)
29. Salmonellosis
30. Shigellosis
31. Staphylococcus Aureus
32. Streptococci
33. Syphilis

INSTRUMENTATION: INFECTIOUS DISEASE ANALYZERS MANUFACTURED BY:

Abbott
Beckman Coulter/Danaher
bioMeriuex
Ortho-Clinical Diagnostics
Roche
Siemens
Tosoh
Wallac, and other suppliers
CURRENT AND EMERGING TECHNOLOGIES
1. Monoclonal Antibodies
2. Immunoassays
  a. Technological Principle
  b. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    Dot Immunobinding Assays
    Capillary Immunoassays
    Particle-Membrane Capture Immunoassay
    Enzyme Amplification
  c. Fluorescent Immunoassays
    Fluorescent Polarization
    Time-Resolved Pulse Fluorescence
  d. Luminescence
    Chemiluminescence
    Bioluminescence
  e. Latex Agglutination
  f. Immunoprecipitation
3. Dry Chemistry
4. Biosensors
5. IT and Automation
6. Molecular Diagnostics
  a. Technology Overview
  b. Amplification Methods
    Polymerase Chain Reaction
    Ligase Chain Reaction
    Branched DNA
    Q-Beta Replicase
    Strand Displacement Activation
    Self-Sustained Sequence Replicase

U.S.A.

A. Market Overview
  1. Business Environment
    a. Health Care Expenditures
    b. Cost Consciousness
    c. Reimbursement
    d. Industry Consolidation
    e. Managed Care
      PPO
      HMO
    f. Hospitals
    g. Admissions
    h. Length of Stay
    i. Industry Diversification
    j. Physician Demographics
    k. Aging Population
      More Chronic Illness
      Disease Incidence
      Susceptibility to latrogenesis
      Multiple Illnesses Cases
  l. Laboratory Regulations
  2. Market Structure
    a. Hospitals
    b. Commercial/Private Laboratories
C. Physician Offices/Group Practices
  1. Market Summary
  2. Market Structure
  3. Test Volume and Sales Forecasts
D. Ancillary Hospital Locations
  1. Introduction
    a. Emergency Departments
    b. Operating Suites
    c. Intensive Care Units
  2. Emergency Departments
    a. Market Summary
    b. Test volume and Sales Forecasts
  3. Operating and Recovery Suites
    a. Market Summary
    b. Test Volume and Sales Forecasts
  4. ICUs/CCUs
    a. Market Summary
    b. Test Volume and Sales Forecasts
E. Cancer Clinics
  1. Introduction
  2. Market Summary
  3. Test Volume and Sales Forecasts
F. Ambulatory Care Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
G. Surgery Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
H. Nursing Homes
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
I. Birth Centers
  1. Introduction
  2. Market Summary
  3. Market Structure
  4. Test Volume and Sales Forecasts
J. Major Suppliers’ Instrument Placements, Installed Base, Reagent Sales and Market Shares

GERMANY

A. Market Overview
B. Market Structure
C. Market Summary
D. Major Suppliers’ Reagent Sales and Market Shares

SPAIN

A. Business Environment
B. Market Structure
C. Market Summary
D. Major Suppliers’ Reagent Sales and Market Shares

MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPANY PROFILE

Abbott
ADI/American Diagnostica
Agilent Technologies
Alere/Biosite/Inverness
Axis-Shield
Beckman Coulter/Danaher
Becton Dickinson
Bio/Data
Biomerieux
Bio-Rad
Cepheid
Chrono-Log
Corgenix
Decode Genetics
Diadexus
Diagnocure
Diagnostica Stago/Trinity Biotech
Diamedix
Diasorin
Eiken Chemical
EKF Diagnostics
Fujirebio
Grifols
Helena Laboratories
Hologic/Gen-Probe
Horiba
Instrumentation Laboratory
International Technidyne/Nexus DX
Kreatech/Leica
Kyowa Medex
Lonza
Mackay Life Sciences
Matritech
Nihon Kohden
Ortho-Clinical Diagnostics
Polartechnics
Polymedco
Qiagen
Roche
SDIX
Sequenom
Siemens
Sienco
Sysmex
Takara Bio
ThermoFisher
Tosoh
Wako
Zycare/Alere

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Infectious Disease Test Volume Forecast
U.S.A., Physician Offices/Group Practices Microbiology Test Volume Forecast
U.S.A., Physician Offices/Group Practices Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Physician Offices/Group Practices Microbiology Reagent and Instrument Sales Forecast
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
U.S.A., Ambulatory Care Centers Microbiology And Serology Test Volume Forecast
U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
U.S.A., Surgery Centers Microbiology And Serology Reagent and Instrument Sales Forecast
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
Germany, Laboratory Performing Diagnostic Tests by Market Segment
Germany, AIDS Testing Market Estimated Market Share of Major Suppliers
Germany, Gonorrhea Testing Market Estimated Market Share of Major Suppliers
Germany, Hepatitis Testing Market Estimated Market Share of Major Suppliers
Germany, Herpes Testing Market Estimated Market Share of Major Suppliers
Germany, Influenza Testing Market Estimated Market Share of Major Suppliers
Germany, Mononucleosis Testing Market Estimated Market Share of Major Suppliers
Germany, Septicemia Testing Market Estimated Market Share of Major Suppliers
Germany, Streptococci Testing Market Estimated Market Share of Major Suppliers
Spain, Laboratory Performing Infectious Disease Tests by Market Segment
Spain, AIDS Testing Market Estimated Market Shares of Major Suppliers
Spain, Chlamydia Testing Market Estimated Market Shares of Major Suppliers
Spain, Hepatitis Testing Market Estimated Market Shares of Major Suppliers
Spain, Herpes Testing Market Estimated Market Shares of Major Suppliers
Spain, Influenza Testing Market Estimated Market Shares of Major Suppliers
Spain, Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
Spain, Rubella Testing Market Estimated Market Shares of Major Suppliers
Spain, Streptococci Testing Market Estimated Market Shares of Major Suppliers
Spain, Syphilis Testing Market Estimated Market Shares of Major Suppliers


More Publications